Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested Capital

AIM ImmunoTech (AIM) Return on Capital Employed (2018 - 2023)

Historic Return on Capital Employed for ImmunoTech (AIM) over the last 3 years, with Q4 2023 value amounting to 1.93%.

  • ImmunoTech's Return on Capital Employed changed N/A to 1.93% in Q4 2023 from the same period last year, while for Dec 2023 it was 1.93%, marking a year-over-year change of. This contributed to the annual value of 4.43% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q4 2023, ImmunoTech's Return on Capital Employed is 1.93%.
  • Over the past 5 years, ImmunoTech's Return on Capital Employed peaked at 0.12% during Q3 2020, and registered a low of 1.93% during Q4 2023.